Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

235
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
235
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

799
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
799
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

504
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
504

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thyroid-Liver Axis: Mechanistic Insights and Clinical Implications.

Cureus·2026
Same author

Screening Early Renal Disease Using Albuminuria in Indian Patients at High Risk.

Kidney international reports·2026
Same author

Pragmatic Use of Thyroid Autoantibodies in Clinical Practice: An Update.

TouchREVIEWS in endocrinology·2026
Same author

Predicted cardiovascular risk reduction with tirzepatide vs. semaglutide: interpretative considerations from the SURMOUNT-5 <i>post hoc</i> analysis.

European heart journal open·2026
Same author

Evaluating the Impact of Insurer-Sponsored Health Coaching on Hospitalization and Costs in India: A Retrospective Cohort Study.

Cureus·2026
Same author

Research priorities for data science and artificial intelligence in global health: an international consensus exercise.

The Lancet. Global health·2026

Related Experiment Video

Updated: Jun 5, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K

Harnessing Digital Initiatives for Improved Health Outcomes in Diabetes Management: An Observational Patient Program.

Bipin Sethi1, Krishna Seshadri2, Vaishali Deshmukh3

  • 1Endocrinology, CARE Hospitals & Transplant Centre and CARE Hospitals, Outpatient Centre, Hyderabad, IND.

Cureus
|December 9, 2024
PubMed
Summary
This summary is machine-generated.

The Zyla app significantly improved glycemic control in diabetes patients, lowering HbA1c, FBS, and PPG levels. This AI-powered tool shows promise for diabetes management, though further research is needed.

Keywords:
diabetes mellituseducation and support interventionmobile applicationsmobile healthpatient management system toolpersonalized care

More Related Videos

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.5K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.2K

Related Experiment Videos

Last Updated: Jun 5, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.5K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.2K

Area of Science:

  • Digital Health
  • Artificial Intelligence in Medicine
  • Diabetes Management

Background:

  • Digital health applications offer potential for diabetes self-management, but evidence of effectiveness is limited.
  • Zyla is an AI-based app providing personalized care management for diabetes patients.
  • This study evaluates the impact of the Zyla app on diabetes disease outcomes.

Purpose of the Study:

  • To assess the effectiveness of the Zyla app in improving diabetes management.
  • To understand the impact of AI-driven personalized care on key health parameters.
  • To evaluate changes in glycemic and lipid profiles among app users.

Main Methods:

  • Retrospective, observational study using data from the Zyla app (2020).
  • Zyla app facilitates personalized care teams (nutritionists, physiotherapists, counselors).
  • Collected data included HbA1c, FBS, PPG, serum creatinine, and lipid profiles.

Main Results:

  • Significant reductions observed in HbA1c, fasting blood sugar (FBS), and post-prandial glucose (PPG) (P<0.0001).
  • Significant decrease in triglycerides (TG) and total cholesterol (TC); non-significant changes in HDL-C and LDL-C.
  • Numerical decrease in serum creatinine, though not statistically significant.

Conclusions:

  • The Zyla app demonstrated significant improvements in glycemic control for diabetes patients.
  • Numerical improvements were noted in kidney function and cholesterol levels.
  • Further rigorous studies are warranted to validate the impact of medical apps in diabetes care in India.